First in vivo gene-editing drugs enter the clinic Sangamo Therapeutics has started dosing patients with gene-editing drugs that are administered directly into the blood.
Para acessar a publicação na íntegra clique aqui
Click here to original publication.
Fonte: NATURE REVIEWS | DRUG DISCOVERY VOLUME 17 | JANUARY 2018